RBR-10nnzgqhRecruitingPhase 3
Prophylaxis for Acute Pancreatitis after Endoscopic Retrograde Cholangiopancreatography (ERCP): clinical, randomized, double-blind trial to evaluate the efficacy of Diclofenac versus Indomethacin and the benefit in risk groups
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18Y to 0 (—)
Inclusion Criteria
- •Patients submitted to Endoscopic Retrograde Cholangiopancreatography; of both sexes; aged over 18 years
Exclusion Criteria
- •Patients under 18 years of age; pregnant women; nursing mothers; those who do not accept or are not able to perform the Endoscopic Retrograde Cholangiopancreatography Exam(s) and follow-up during the study; Patients who lost clinical and laboratory follow-up due to hospital transfer or early death from severe cholangitis; patients with Non-steroidal anti-inflammatory drugs (NSAID) allergy and contraindication for use (i.e., active peptic ulcer, serum creatinine >1.4mg/dL, and single kidney) will also be excluded
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Prevention of Acute Pancreatitis after the Endoscopic Cholangiography procedure with the use of the drug IndomethacipancreatitisOther acute pancreatitisCapítulo XIRBR-5g7hghvServiço de Neurorradiologia do Hospital São José do Complexo Hospitalar Santa Casa de Misericórdia de Porto Alegre
Completed
Phase 4
Prevention of pancreatic inflammation after endoscopy of the pancreas and bile duct with anti-inflammatoryacute pancreatitisRBR-6zkm5kJulio Carlos Pereira Lima
Unknown
Phase 1
Prevention of Acute Pancreatitis After Endoscopic InterventionsCholangiolitisAcute PancreatitisNCT04608760Vitebsk State Medical University90
Recruiting
Not Applicable
Prophylaxis of post-ERCP pancreatitis by the intravenous administration of the non-steroidal anti-inflammatory drugPost-ERCP pancreatitisJPRN-UMIN000013193Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine, Tokyo, Japan400
Recruiting
Not Applicable
Prevention of Post-ERCP Pancreatitis by Intraduodenal Indomethacin in ERCP naïve patientsKCT0002394Chung-Ang Univerisity Hospital926